Injectable hydrogel platform for long-lasting treatment of chronic pain conditions including knee osteoarthritis.
Relevium Medical is a biopharmaceutical company developing novel hydrogel-based injectable treatments for chronic pain by combining natural biopolymers with pharmacologically active agents. Their lead program targets knee osteoarthritis with a product designed to reduce repeat injections and opioid dependence. The company has received $3.7M in non-dilutive funding and completed preclinical testing demonstrating safety and selective nerve blockade. Relevium Medical is a product of Relevium Medical.